IRVINE, Calif., Nov. 01, 2021 — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare, genetic, mitochondrial diseases, today announced that it will be participating in the following investors conferences during the month of November. Conference and presentation details are as follows:… Continue reading Reneo Pharmaceuticals to Participate at Upcoming Investor Conferences
